Top

Journal of Gastrointestinal Cancer

Published in:

14-09-2021 | Endoscopy | Review Article

The Impact of the COVID-19 Epidemic on Diagnosis, Treatment, Concerns, Problems, and Mental Health in Patients with Gastric Cancer

Authors: Fatemeh Baghernezhad Hesary, Hamid Salehiniya

Published in: Journal of Gastrointestinal Cancer | Issue 3/2022

Abstract

Introduction

COVID-19 epidemic has had different effects on many diseases, including gastric cancer. Due to COVID-19 epidemic the importance of knowing the effects of the epidemic in patients to deal with it, the present study aimed to investigate the effect of COVID-19 on the diagnosis, treatment, concerns, problems, and mental health of patients with gastric cancer.

Methods

The present study was a systematic review by searching the PubMed, Scopus, and Web of Science databases with the keywords of COVID-19 and gastric cancer. The articles that addressed any aspect of COVID-19 epidemic on diagnosis, treatment, problems, and mental health in patients with gastric cancer were included; the data were qualitatively summarized and presented in related tables.

Results

A total 22 articles were included. The effects of COVID-19 on gastric cancer were divided into four categories of the effects of COVID-19 on the diagnosis, treatment and follow-up, concerns, and problems and mental health of patients with gastric cancer. The COVID-19 epidemic has reduced the number of screenings, altered treatment, and delayed or discontinued treatment, which caused problems and concerns such as sleep disturbances and stress.

Conclusion

Considering the effects of COVID-19 epidemic on gastric cancer and on the other hand, the continuation of the epidemic in the society, it is necessary for the officials and experts of the health system to design and implement necessary interventions to minimize the negative effects of epidemic on patients with gastric cancer.

Zhang H, Yin J, Wang X, Yuan D, Zhu K, Li K. Patients’ responses to the sudden interruption of chemotherapy during the outbreak of the novel coronavirus: a cross-sectional study. 2021;13:351–8.

Brito M, Laranjo A, Sabino J, Oliveira C, Mocanu I, Fonseca J. Digestive oncology in the COVID-19 pandemic era. GE Port J Gastroenterol.

Baghernezhad Hesary F, Salehiniya H, Miri M, Moodi M. Investigating preventive behaviors toward COVID-19 among Iranian people. Front Public Health 2021;9(590105).

Buscarini E, Benedetti A, Monica F, Pasquale L, Buttitta F, Cameletti M, et al. Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: A nationwide survey. Curr Oncol. 2021.

Longcroft-Wheaton G, Tolfree N, Gangi A, Beable R, Bhandari P. Data from a large Western centre exploring the impact of COVID-19 pandemic on endoscopy services and cancer diagnosis. 2021;12(3):193–9.

Almasi Z, Mohammadian-Hafshejani A, Salehiniya H. Incidence, mortality, and epidemiological aspects of cancers in Iran; differences with the world data. JBUON. 2016;21(4):994–1004.PubMed

Zahedi A, Rafiemanesh H, Enayatrad M, Ghoncheh M, Salehiniya H. Incidence, Trends and epidemiology of cancers in North West of Iran. Asian Pac J Cancer Prev. 2015;16(16):7189–93.CrossRef

Mohammadian M, Pakzad R, Towhidi F, Makhsosi M, Ahmadi A, Salehiniya H. Incidence and mortality of kidney cancer and its relationship with HDI (Human Development Index) in the world in 2012. Public Health Clujul Medical. 2016;90(3):286–93.

Yusefi A, BagheriLankarani K, Bastani P, RadinManesh M, Kavosi Z. Risk factors for gastric cancer: a systematic review. Asian pac j cancer prev. 2018;19(3):591–603.PubMedPubMedCentral

10.

Alkatout I, Biebl M, Momenimovahed Z, Giovannucci E, Hadavandsiri F, Salehiniya H, et al. Has COVID-19 affected cancer screening programs? A systematic review. Front Oncol. 2021;11:675038.

11.

Aguayo WG, Moyon FX, Molina GA, Moyon MA, Rivadeneira DJ, Rojas CL, et al. A bleeding GIST in pandemic times, a cooperative approach to a delayed complication, a case report. Int J Surg Case Rep. 2020;77:880–4.CrossRef

12.

Cai M, Wang G, Wu Y, Wang Z, Wang G, Tao K. Study of the gastrointestinal tumor progression during the COVID-19 epidemic in Wuhan. Br J Surg. 2020;107(11):e502–3.PubMedPubMedCentral

13.

Erdem D, Karaman I. Awareness and perceptions related to COVID-19 among cancer patients: A survey in oncology department. 2020;29(6):e13309.

14.

Penson D, Krishnaswami S, Jules A, Seroogy J, McPheeters M. Evaluation and treatment of cryptorchidism. comparative effectiveness review no. 88. (Prepared by the Vanderbilt Evidence-based Practice Center under Contract No. 290–2007–10065-I.) AHRQ Publication No. 13-EHC001-EF. Agency for Healthcare Research and Quality 2012.

15.

De Vincentiis L, Carr RA, Mariani MP, Ferrara G. Cancer diagnostic rates during the 2020 “lockdown”, due to COVID-19 pandemic, compared with the 2018–2019: An audit study from cellular pathology. J Clin Pathol. 2021;74(3):187–9.CrossRef

16.

Huang K, Zhao X, Chen X, Gao Y, Yu J, Wu L. Analysis of digestive endoscopic results during COVID-19. J Transl Int Med. 2021;9(1):38–42.CrossRef

17.

Lantinga MA, Theunissen F, Ter Borg PCJ, Bruno MJ, Ouwendijk RJT, Siersema PD. Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database. Endoscopy. 2021;53(2):166–70.CrossRef

18.

Lui TKL, Leung K, Guo CG, Tsui VWM, Wu JT, Leung WK. Impacts of the coronavirus 2019 pandemic on gastrointestinal endoscopy volume and diagnosis of gastric and colorectal cancers: a population-based study. Gastroenterology. 2020;159(3):1164-6.e3.CrossRef

19.

Manes G, Saibeni S, Pellegrini L, Picascia D, Pace F, Schettino M, et al. Improvement in appropriateness and diagnostic yield of fast-track endoscopy during the COVID-19 pandemic in Northern Italy. Endoscopy. 2021;53(2):162–5.CrossRef

20.

Akhtar N, Rajan S, Chakrabarti D, Kumar V, Gupta S, Misra S, et al. Continuing cancer surgery through the first six months of the COVID-19 pandemic at an academic university hospital in India: A lower-middle-income country experience. J Surg Oncol. 2021;123(5):1177–87.CrossRef

21.

de Joode K, Dumoulin DW, Engelen V, Bloemendal HJ, Verheij M, van Laarhoven HWM, et al. Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective. Eur J Cancer. 2020;136:132–9.CrossRef

22.

Takahari D, Shinozaki E, Wakatsuki T, Ooki A, Ozaka M, Suzuki T, et al. Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research. Int J Clin Oncol. 2021;26(2):335–44.CrossRef

23.

Wahed S, Chmelo J, Navidi M, Hayes N, Phillips AW, Immanuel A. Delivering esophago-gastric cancer care during the COVID-19 pandemic in the United Kingdom: a surgical perspective. Eur J Cancer Care (Engl). 2020;33(9).

24.

Chia JMX, Goh ZZS, Chua ZY, Ng KYY, Ishak D, Fung SM, et al. Managing cancer in context of pandemic: A qualitative study to explore the emotional and behavioural responses of patients with cancer and their caregivers to COVID-19. BMJ Open. 2021;11(1).

25.

Pigozzi E, Tregnago D, Costa L, Insolda J, Turati E, Rimondini M, et al. Psychological impact of Covid-19 pandemic on oncological patients: a survey in Northern Italy. PLoS One. 2021;16(3 March).

26.

Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno H, Chang S, et al. Stress and symptom burden in oncology patients during the COVID-19 pandemic. J Pain Symptom Manage. 2020;60(5):e25–34.CrossRef

27.

ASH Registry Offers Insights on COVID-19 in Patients with hematologic malignancies. Oncologist. 2021;26(S1):S17–S8.

28.

Armellini E, Repici A, Alvisi C, Dinelli M, Gambitta P, Manes G, et al. Analysis of patients attitude to undergo urgent endoscopic procedures during COVID-19 outbreak in Italy. Dig Liver Dis. 2020;52(7):695–9.CrossRef

29.

Giuliani J, Bonetti A. COVID-19 and cancer: A clear change not only in daily clinical practice but also in clinical research management. J Med Virol. 2021;93(5):2564–5.CrossRef

30.

Bartlett DL, Howe JR, Chang G, Crago A, Hogg M, Karakousis G, et al. Management of cancer surgery cases during the COVID-19 pandemic: considerations. Ann Surg Oncol. 2020;27(6):1717–20.CrossRef

31.

Aznab M. Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic. Int J Clin Oncol. 2020;25(9):1581–6.CrossRef

32.

Gralnek IM, Hassan C, Dinis-Ribeiro M. COVID-19 and endoscopy: implications for healthcare and digestive cancer screening. Nat Rev Gastroenterol Hepatol. 2020;17(8):444–6.CrossRef

33.

González-Montero J, Valenzuela G, Ahumada M, Barajas O, Villanueva L. Management of cancer patients during COVID-19 pandemic at developing countries. World J Clin Cases. 2020;8(16):3390–404.CrossRef

Title: The Impact of the COVID-19 Epidemic on Diagnosis, Treatment, Concerns, Problems, and Mental Health in Patients with Gastric Cancer
Authors: Fatemeh Baghernezhad Hesary
Hamid Salehiniya
Publication date: 14-09-2021
Publisher: Springer US
Keywords: Endoscopy
Gastric Cancer
Gastric Cancer
COVID-19
Published in: Journal of Gastrointestinal Cancer / Issue 3/2022
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-021-00692-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The Impact of the COVID-19 Epidemic on Diagnosis, Treatment, Concerns, Problems, and Mental Health in Patients with Gastric Cancer

Abstract

Introduction

Methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2022

Identifying the Risk Factors for Mortality in Patients with Cancer and COVID-19 in Hamadan, the West of Iran

Significant Response to Camrelizumab Plus Targeted Drugs in Recurrent Intrahepatic Cholangiocarcinoma: a Case Report and Literature Review

Procalcitonin and C-Reactive Protein as an Early Predictor of Infection in Elective Gastrointestinal Cancer Surgery—a Prospective Observational Study

The Activity and Polymorphism of the PON1 in Patients with Chronic Liver Disease: a Systematic Review and Meta-analysis

A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index

Choosing the Appropriate Individualized Adjuvant Chemotherapy in Stage III Colon Cancer Patients Under and Over 70 Years

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page